KIMBERLY SCHULMEISTER: Open Payments
NPI 1831629781 · LENEXA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 43 payments from 15 companies in 2025. Trend: 2023 $444 · 2024 $1,359 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 4 | $190 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $183 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $81 |
| HEARTFLOW, INC. | 4 | $79 |
| Alnylam Pharmaceuticals Inc. | 4 | $72 |
| Merck Sharp & Dohme LLC | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| BridgeBio Pharma, Inc. | 2 | $39 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| PFIZER INC. | 1 | $23 |
Products named: JARDIANCE, LifeVest, FFRct, AMVUTTRA, VERQUVO, Kerendia, Attruby, INSPIRE.
Industry payments across KS — which companies pay providers there.
